Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Sihuan Pharmaceutical Holdings Group Ltd

+ Add to Watchlist

TEL1:GR

0.563 EUR 0.002 0.35%

As of 15:17:12 ET on 01/30/2015.

Snapshot for Sihuan Pharmaceutical Holdings Group Ltd (TEL1)

Open: 0.565 Day's Range: 0.546 - 0.575 Volume: 0
Previous Close: 0.565 52wk Range: 0.369 - 0.862 1-Yr Rtn: +48.01%

Stock Chart for TEL1

No chart data available.
  • TEL1:GR 0.565
  • 1D
  • 1M
  • 1Y
0.565
Interactive TEL1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TEL1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 23.6532
Relative P/E vs. DAX -
Earnings Per Share (CNY) (ttm) -
Est. EPS (CNY) (12/2014) 0.1680
Est. PEG Ratio 1.0420
Market Cap (M EUR) 5,835.03
Shares Outstanding (M) 10,364.18
30 Day Average Volume 11,986
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.51%
Cash Dividend (CNY) 0.0130
Dividend Ex-Date 09/10/2014
5 Year Dividend Growth -
Next Earnings Announcement 03/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TEL1

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for TEL1

Sihuan Pharmaceutical Holdings Group Ltd. researches and develops cardiocerebral vascular drugs in China. The Company drugs address needs in the areas of anti-infective, metabolism, cardiovascular system, oncology and nervous system.

Che FengshengChairman/Exec Dir/Co-FounderGuo WeichengDpty Chairman/CEO/Executive Director
Choi Yiau ChongCFO/Joint SecretaryJia ZhongxinChief Operating Officer
More Company Profile & Key Executives for TEL1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil